The Journal of Medical Microbiology, Vol 48, Issue 12 1103-1106, Copyright © 1999 by Society for General Microbiology

JOURNAL ARTICLE

Relationship between mutations in parC and gyrA of clinical isolates of Streptococcus pneumoniae and resistance to ciprofloxacin and grepafloxacin

B. A. Stewart, A. P. Johnson and N. Woodford
Microbiology and Virology Clinical Group, Royal Hospitals HNS Trust, London.

The mechanisms of resistance to ciprofloxacin and grepafloxacin were studied in 54 clinical isolates of Streptococcus pneumoniae. Restriction fragment length polymorphism analysis following HinfI digestion was used with DNA sequencing to identify mutations in the quinolone resistance-determining regions (QRDRs) of the parC and gyrA genes. Ciprofloxacin MICs up to 16 mg/L were not associated with mutations to these genes in approximately half of the isolates. In other isolates, moderate levels of ciprofloxacin resistance (MIC 8-16mg/L) were associated with an alteration of ParC, most commonly entailing replacement of serine-79 by phenylalanine. High-level ciprofloxacin resistance (MIC 32-128 mg/L) entailed the additional mutation of GyrA with substitution of serine-83 by phenylalanine. Grepafloxacin MICs >4 mg/L were associated with this GyrA mutation alone; no relationship was detected between grepafloxacin MICs and mutation of the QRDR of parC.

This article has been cited by other articles:

				A. P. Johnson, C. L. Sheppard, S. J. Harnett, A. Birtles, T. Harrison, N. P. Brenwald, M. J. Gill, R. A. Walker, D. M. Livermore, and R. C. George Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England J. Antimicrob. Chemother., December 1, 2003; 52(6): 953 - 960. [Abstract] [Full Text] [PDF]

				K. L. F. Cooper and R. V. Goering Development of a Universal Probe for Electronic Microarray and Its Application in Characterization of the Staphylococcus aureus polC Gene J. Mol. Diagn., February 1, 2003; 5(1): 28 - 33. [Abstract] [Full Text] [PDF]

				S.-i. Yokota, K. Sato, O. Kuwahara, S. Habadera, N. Tsukamoto, H. Ohuchi, H. Akizawa, T. Himi, and N. Fujii Fluoroquinolone-Resistant Streptococcus pneumoniae Strains Occur Frequently in Elderly Patients in Japan Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3311 - 3315. [Abstract] [Full Text] [PDF]

				J. E. Morris, X.-S. Pan, and L. M. Fisher Grepafloxacin, a Dimethyl Derivative of Ciprofloxacin, Acts Preferentially through Gyrase in Streptococcus pneumoniae: Role of the C-5 Group in Target Specificity Antimicrob. Agents Chemother., February 1, 2002; 46(2): 582 - 585. [Abstract] [Full Text] [PDF]

				S. Hartman-Neumann, K. DenBleyker, L. A. Pelosi, L. E. Lawrence, J. F. Barrett, and T. J. Dougherty Selection and Genetic Characterization of Streptococcus pneumoniae Mutants Resistant to the Des-F(6) Quinolone BMS-284756 Antimicrob. Agents Chemother., October 1, 2001; 45(10): 2865 - 2870. [Abstract] [Full Text]